Cyclenium Pharma

7 articles about Cyclenium Pharma

• Cyclenium Pharma and Vuja De Sciences Announce Oncology Drug Discovery Collaboration

  1/5/2022

  Cyclenium Pharma, Inc. and Vuja De Sciences, Inc. have announced today the signing of a drug discovery collaboration agreement.

• 

  Several Players Begin 2022 with New Partnerships in Place

  1/5/2022

  ​It's been a busy day for collaboration announcements in the life sciences world. Here are some of the top stories for today.

• AiCuris to Cooperate with Cyclenium Pharma to Develop Novel Anti-Infectives

  10/1/2018

  AiCuris Anti-infective Cures GmbH and Cyclenium Pharma Inc. announced today the signing of a collaboration agreement focused on finding new pharmaceutical compounds for the treatment and prevention of bacterial and viral diseases.

• 

  Mosquitoes Will Rule the Earth as Climate Change Expands Disease Vectors

  9/26/2018

  Politicians might deny climate change, but disease-carrying insects and their pathogens aren’t—they’re exploiting it.

• Cyclenium Pharma Announces Drug Discovery Collaboration Agreement with Ono Pharmaceutical

  12/12/2017

  Cyclenium will receive an upfront payment and research funding from Ono, as well as development milestones and royalties on marketed products.

• Cyclenium Announces A Research Collaboration With Hospital For Sick Children To Identify Novel Macrocyclic Modulators For Pharmacological Targets In Multiple Therapeutic Areas

  3/7/2017

• Cyclenium And Haplogen Announce Drug Discovery Collaboration

  5/7/2015